Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovis (ENOV) Asset Writedowns and Impairment (2018 - 2025)

Enovis (ENOV) has disclosed Asset Writedowns and Impairment for 6 consecutive years, with $1.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 62.81% to $1.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a 160.57% increase, with the full-year FY2025 number at $1.0 billion, up 61.42% from a year prior.
  • Asset Writedowns and Impairment was $1.0 billion for Q4 2025 at Enovis, up from $644.8 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.0 billion in Q4 2025 to a low of -$67.8 million in Q2 2024.
  • A 3-year average of $283.3 million and a median of $62.7 million in 2023 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 30.5% in 2024, then skyrocketed 62.81% in 2025.
  • Enovis' Asset Writedowns and Impairment stood at -$52.0 million in 2023, then skyrocketed by 1340.12% to $644.8 million in 2024, then surged by 62.81% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for ENOV's Asset Writedowns and Impairment are $1.0 billion (Q4 2025), $644.8 million (Q4 2024), and -$67.8 million (Q2 2024).